New treatments for Huntington’s disease
New treatments for Huntington’s disease
批准号:
nhmrc : 1124356
负责人:
Dr Thibault Renoir
金额:
$46.01万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2017
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2017-01-01 至 2019-12-31
中文摘要
亨廷顿氏病(HD)是一种破坏性的神经退行性疾病,其与阿尔茨海默氏病和帕金森氏病(即痴呆样认知缺陷)具有若干特征。目前还没有治愈HD的方法。使用HD的小鼠模型和针对导致HD的事件级联的两个不同水平的相关药物(即N-乙酰半胱氨酸和去铁酮)的组合,我们将减缓疾病的进展并纠正大脑内的功能障碍。
英文摘要
Huntington’s disease (HD) is a devastating neurodegenerative disorder which shares several features with Alzheimer’s and Parkinson’s disease (i.e. dementia-like cognitive deficits). There is currently no cure for HD. Using a mouse model of HD and a combination of relevant drugs (i.e. N-Acetylcysteine and deferiprone) targeting two distinct levels of the cascade of events leading to HD, we will slow down the progression of the disease and correct dysfunctions within the brain.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Gene-environment interactions in Dementia
-
批准号:nhmrc : GNT1136529
-
项目类别:Boosting Dementia Research Initiative
-
资助金额:$72.01万
-
财政年份:2017
-
负责人:Dr Thibault Renoir
-
依托单位:
Gene-environment interactions in Dementia
-
批准号:nhmrc : 1136529
-
项目类别:Targeted Calls
-
资助金额:$48.64万
-
财政年份:2017
-
负责人:Dr Thibault Renoir
-
依托单位:
Gene-environment interactions in the regulation of neuroplasticity and cognitive function
-
批准号:DE140100588
-
项目类别:Discovery Early Career Researcher Award
-
资助金额:$27.63万
-
财政年份:2014
-
负责人:Dr Thibault Renoir
-
依托单位:
Developing new Therapeautic Approaches to Depression Through behavioural, cellular and molecular analyses in a progressi
-
批准号:nhmrc : 629044
-
项目类别:Early Career Fellowships
-
资助金额:$4.96万
-
财政年份:2010
-
负责人:Dr Thibault Renoir
-
依托单位:
海外基金